False claims that COVID-19 mRNA vaccines cause cancer could, ironically, lead to worse cancer outcomes by undermining a promising tool to prevent and treat it.

After pushback, the agency reversed course and agreed to review Moderna’s application after all.

The move signals an escalation in the agency’s efforts to interfere with established procedures for testing and approving vaccines.

Key Takeaways